Bellerophon Therapeutics, Inc.
BLPHDelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600132
Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Bellerophon Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 22 | 19 | −3 |
| Shares | 1.14M | 1.14M | +676 (+0.1%) |
| Value | $2.68M | $1.40M | −$1.28M (−47.8%) |
New holders (3)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sepio Capital, LP | 23,800 | $29.0K | 0.00% |
| Susquehanna International Group, LLP | 14,335 | $18.0K | 0.00% |
| Destination Wealth Management | 10,000 | $12.0K | 0.00% |
Sold out (6)
Institutions that held Bellerophon Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Jane Street Group, LLC | 37,327 | $88.0K |
| Millennium Management LLC | 11,075 | $26.0K |
| UBS Group AG | 2,571 | $6.00K |
| Federated Hermes, Inc. | 153 | $1.00K |
| Bank of America Corp | 43 | $0 |
| Citigroup Inc | 86 | $0 |